List of insiders holdings for MyoKardia Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | STARR KEVIN P Director 10% Owner |
2018-03-07 16:01:02 | 224,744 2,885,104 |
3,109,848 | Form 4 |
2 | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC LEVIN MARK J TEPPER ROBERT I 10% Owner |
2018-01-05 16:30:40 | 1,102,356 0 |
1,102,356 | Form 4 |
3 | Lee June EVP, Chief Development Officer |
2019-10-29 20:31:45 | 1,067,001 0 |
1,067,001 | Form 4 |
4 | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC LEVIN MARK J TEPPER ROBERT I 10% Owner |
2019-02-13 16:08:03 | 304,378 0 |
304,378 | Form 13G |
5 | Fox Jonathan C Chief Medical Officer |
2016-05-06 16:20:54 | 240,997 0 |
240,997 | Form 4 |
6 | LADD CYNTHIA J General Counsel |
2020-02-19 20:44:36 | 41,113 0 |
41,113 | Form 4 |
7 | Lambing Joseph See Remarks |
2019-02-12 16:27:41 | 33,400 0 |
33,400 | Form 4 |
8 | Semigran Marc Chief Medical Officer |
2019-02-12 16:31:11 | 33,400 0 |
33,400 | Form 4 |
9 | Chan Steven See Remarks |
2017-01-20 17:41:08 | 25,000 0 |
25,000 | Form 4 |
10 | TOPOL ERIC Director |
2017-06-16 16:11:55 | 11,000 0 |
11,000 | Form 4 |
11 | HOMCY CHARLES J Director |
2016-12-01 17:25:16 | 6,496 0 |
6,496 | Form 4 |
12 | Meeker David P Director |
2020-11-19 20:26:35 | 0 0 |
0 | Form 4 |
13 | McDowell Robert Scott Chief Scientific Officer |
2020-11-19 20:26:09 | 0 0 |
0 | Form 4 |
14 | Harris Taylor C. Chief Financial Officer |
2020-11-19 20:21:28 | 0 0 |
0 | Form 4 |
15 | AGARWAL SUNIL Director |
2020-11-19 20:20:50 | 0 0 |
0 | Form 4 |
16 | Fairey William EVP, Chief Commercial Officer |
2020-11-19 20:20:48 | 0 0 |
0 | Form 4 |
17 | Bauer Jake Chief Business Officer |
2020-11-19 20:19:58 | 0 0 |
0 | Form 4 |
18 | PERRY MARK L Director |
2020-11-19 20:19:50 | 0 0 |
0 | Form 4 |
19 | Popovits Kimberly J Director |
2020-11-19 20:16:28 | 0 0 |
0 | Form 4 |
20 | CRANSTON MARY B Director |
2020-11-19 20:16:24 | 0 0 |
0 | Form 4 |
21 | GIANAKAKOS ANASTASIOS President and CEO |
2020-11-19 20:15:34 | 0 0 |
0 | Form 4 |
22 | YARNO WENDY L Director |
2020-11-19 20:15:33 | 0 0 |
0 | Form 4 |
23 | Waynick Denelle J Chief Legal Officer |
2020-11-19 20:13:35 | 0 0 |
0 | Form 4 |
24 | Sanofi 10% Owner |
2019-02-15 06:12:34 | 0 0 |
0 | Form 13G |